Personal information

No personal information available

Activities

Collapse all

Employment (1)

Johns Hopkins University: Baltimore, MD, US

2019-04-01 to present (Oncology)
Employment
Source: Self-asserted source
Tanguy Seiwert

Works (18)

Lower survival for surgical treatment of human papillomavirus–related oropharynx cancer at community cancer centers

JNCI: Journal of the National Cancer Institute
2025-03-01 | Journal article
DOI: 10.1093/jnci/djae220
Contributors: Danielle R Trakimas; Wojciech K Mydlarz; Leila J Mady; Christine G Gourin; Wayne Koch; Nyall R London, Jr; Harry Quon; Ana P Kiess; Tanguy Y Seiwert; Carole Fakhry
Source: check_circle
Crossref

Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard‐of‐care?

Cancer
2024-03-15 | Journal article
DOI: 10.1002/cncr.35198
Contributors: Neil D. Gross; Tanguy Y. Seiwert
Source: check_circle
Crossref

Clinical Uncertainties of Circulating Tumor DNA in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma in the Absence of National Comprehensive Cancer Network Guidelines

Journal of Clinical Oncology
2023-05-10 | Journal article
DOI: 10.1200/JCO.22.00264
Contributors: Deborah X. Xie; Carmen Kut; Harry Quon; Tanguy Y. Seiwert; Gypsyamber D'Souza; Carole Fakhry
Source: check_circle
Crossref

Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma

npj Precision Oncology
2023-04-11 | Journal article
DOI: 10.1038/s41698-023-00378-9
Contributors: Jacob J. Adashek; Surendra Sapkota; Rodrigo de Castro Luna; Tanguy Y. Seiwert
Source: check_circle
Crossref

Data from Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.c.6533137
Contributors: Charu Aggarwal; Nabil F. Saba; Alain Algazi; Ammar Sukari; Tanguy Y. Seiwert; Missak Haigentz; Mercedes Porosnicu; Marcelo Bonomi; Jean Boyer; Mark T. Esser et al.
Source: check_circle
Crossref

Data from Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.c.6533137.v1
Contributors: Charu Aggarwal; Nabil F. Saba; Alain Algazi; Ammar Sukari; Tanguy Y. Seiwert; Missak Haigentz; Mercedes Porosnicu; Marcelo Bonomi; Jean Boyer; Mark T. Esser et al.
Source: check_circle
Crossref

Supplementary Figures S1-S9 from Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22490338
Contributors: Charu Aggarwal; Nabil F. Saba; Alain Algazi; Ammar Sukari; Tanguy Y. Seiwert; Missak Haigentz; Mercedes Porosnicu; Marcelo Bonomi; Jean Boyer; Mark T. Esser et al.
Source: check_circle
Crossref

Supplementary Figures S1-S9 from Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22490338.v1
Contributors: Charu Aggarwal; Nabil F. Saba; Alain Algazi; Ammar Sukari; Tanguy Y. Seiwert; Missak Haigentz; Mercedes Porosnicu; Marcelo Bonomi; Jean Boyer; Mark T. Esser et al.
Source: check_circle
Crossref

Supplementary Tables S1-S3 from Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22490335
Contributors: Charu Aggarwal; Nabil F. Saba; Alain Algazi; Ammar Sukari; Tanguy Y. Seiwert; Missak Haigentz; Mercedes Porosnicu; Marcelo Bonomi; Jean Boyer; Mark T. Esser et al.
Source: check_circle
Crossref

Supplementary Tables S1-S3 from Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22490335.v1
Contributors: Charu Aggarwal; Nabil F. Saba; Alain Algazi; Ammar Sukari; Tanguy Y. Seiwert; Missak Haigentz; Mercedes Porosnicu; Marcelo Bonomi; Jean Boyer; Mark T. Esser et al.
Source: check_circle
Crossref

The role of macrophages in the tumor microenvironment and tumor metabolism

Seminars in Immunopathology
2023-03 | Journal article
DOI: 10.1007/s00281-023-00988-2
Contributors: Pritam Sadhukhan; Tanguy Y. Seiwert
Source: check_circle
Crossref

Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research
2023-02-01 | Journal article
DOI: 10.1158/1078-0432.CCR-22-1987
Contributors: Charu Aggarwal; Nabil F. Saba; Alain Algazi; Ammar Sukari; Tanguy Y. Seiwert; Missak Haigentz; Mercedes Porosnicu; Marcelo Bonomi; Jean Boyer; Mark T. Esser et al.
Source: check_circle
Crossref

Spontaneous regression of an human papillomavirus‐positive oropharyngeal squamous cell carcinoma

Head & Neck
2023-01 | Journal article
DOI: 10.1002/hed.27226
Contributors: Stefanie Seo; Lisa Rooper; Tanguy Y. Seiwert; Carole Fakhry
Source: check_circle
Crossref

Reply to “Guarantee‐time bias in studies on the relationship between immune‐related adverse events and antitumor activity”

Cancer
2022-07 | Journal article
DOI: 10.1002/cncr.34242
Contributors: Corey C. Foster; Tanguy Y. Seiwert
Source: check_circle
Crossref

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

Journal for ImmunoTherapy of Cancer
2022-02 | Journal article
DOI: 10.1136/jitc-2021-003026
Contributors: Robert I Haddad; Tanguy Y Seiwert; Laura Q M Chow; Shilpa Gupta; Jared Weiss; Iris Gluck; Joseph P Eder; Barbara Burtness; Makoto Tahara; Bhumsuk Keam et al.
Source: check_circle
Crossref

Treatment De-intensification for HPV-Positive Oropharynx Cancer: What Is Currently Acceptable?

Journal of Clinical Oncology
2021-08-20 | Journal article
DOI: 10.1200/JCO.21.00594
Contributors: Anthony J. Cmelak; Robert L. Ferris; Allen M. Chen; Tanguy Seiwert; Barbara Burtness
Source: check_circle
Crossref

Time to Debunk an Urban Myth? The “Abscopal Effect” With Radiation and Anti–PD-1

Journal of Clinical Oncology
2020-09-28 | Journal article
DOI: 10.1200/JCO.20.02046
Contributors: Tanguy Y. Seiwert; Ana P. Kiess
Source: check_circle
Crossref

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study

Cancer
2020-07-15 | Journal article
DOI: 10.1002/cncr.32929
Contributors: Tanguy Y. Seiwert; Sara Kochanny; Kevin Wood; Francis P. Worden; Douglas Adkins; James L. Wade; Bethany G. Sleckman; Daniel Anderson; Ryan J. Brisson; Theodore Karrison et al.
Source: check_circle
Crossref

Peer review (2 reviews for 2 publications/grants)

Review activity for Journal for immunotherapy of cancer. (1)
Review activity for Nature communications (1)
How many people are using ORCID?